| Kidney Transplant Low-AGE Diet Study (NCT05104242) | University Hospitals of Derby and Burton NHS Foundation Trust | 2022-02-04 |
| Safety and Effectiveness of COVID-19 Vaccine in Kidney Transplant Recipients (NCT05156086) | Seoul National University Hospital | 2021-11-16 |
| Study Assessing the Safety and Efficacy of Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN (NCT04572854) | Apellis Pharmaceuticals, Inc. | 2021-09-07 |
| Cognitive Outcomes in Stable Renal Transplant Patients Switched fromTacrolimus to Envarsus XR™ (NCT04838288) | Vanderbilt University Medical Center | 2021-06-22 |
| Influence of the Intestinal Microbiota on the Clinical Course of Renal Transplantation (NCT04874896) | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | 2020-12-01 |
| Efficacy and Safety Study of Aspirin for the Prevention of Renal Artery Stenosis in Renal Transplantation Recipients (NCT04260828) | Henan Provincial People's Hospital | 2020-02-28 |
| AZD1656 in Transplantation With Diabetes tO PromoTe Immune TOleraNce (NCT05216172) | Queen Mary University of London | 2019-12-13 |
| Trial to Define the Benefits and Harms of Deceased Donor Kidney Procurement Biopsies (NCT03837522) | St. Louis University | 2019-09-17 |
| IVIG/Rituximab vs Rituximab in Kidney Transplant With de Novo Donor-specific Antibodies (NCT04033276) | Seoul National University Hospital | 2019-01-08 |
| The Kidney and The Brain Study - Assessment of Cognitive Impairment in Advanced CKD (NCT03382444) | Natalie Garratt | 2018-02-20 |
| The Effect of Norepinephrine Versus Dopamine in Renal Transplant Recipients on Postoperative Graft Function (NCT03107858) | Assiut University | 2017-11-01 |
| Characterization Of the Intestinal Microbiome Evolution After Kidney Transplant Donation or Receipt (NCT03043339) | Emory University | 2017-10-02 |
| Efficacy of Envarsus XR and Digital Health Technology in Reducing Tacrolimus Fluctuation and Frequency of Dose Changes (NCT04711291) | Beth Israel Deaconess Medical Center | 2017-06-01 |
| Effects of Nocturnal Hypertension on Sleep Quality in Renal Transplant Recipients (NCT03651492) | Federico II University | 2017-06-01 |
| Study of Pharmacogenomic-Guided Tacrolimus Dosing and Monitoring in Kidney Transplant Recipients (NCT03020589) | University of North Carolina, Chapel Hill | 2017-02-06 |
| Assessment of Effectiveness of Belatacept Patient Alert Card in Patients Following Renal Transplantation in a Sample of EU Countries (NCT02581644) | Bristol-Myers Squibb | 2016-11-29 |
| Treg Therapy in Subclinical Inflammation in Kidney Transplantation (NCT02711826) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-09-20 |
| Pregnancy Outcomes in Renal Transplant Recipients (NCT03073434) | Unity Health Toronto | 2016-03-01 |
| Influence of Thymoglobuline on Phenotypic and Functional Profiles of B Lymphocytes in Renal Transplant Recipients (NCT02894606) | University Hospital, Brest | 2015-02-09 |
| Extracorporeal Shockwave Therapy in the Treatment for Erectile Dysfunction in Male Renal Transplant Recipients (NCT02412345) | University of Sao Paulo | 2015-01-01 |
| Belatacept (Nulojix) in Renal Transplant Recipient With Mild Immunologic Risk Factor: a Pilot Prospective Study. (NCT02738918) | Assistance Publique - Hôpitaux de Paris | 2014-12-01 |
| Renal Transplant Injury and the Renin-Angiotensin System in Kids (RETASK) (NCT03317925) | Wake Forest University Health Sciences | 2014-07-16 |
| A Randomized Study Assess the Safety and Efficacy of Tacrolimus vs Prograf® in Renal Transplantation Treatment (NCT01244659) | EMS | 2014-05-01 |
| Evaluation of a Predictive Immunovirological Test Occurrence of BK Virus Nephropathy in Renal Transplant (NCT02049827) | Centre Hospitalier Universitaire de Nice | 2014-02-19 |
| Evaluation of Calcineurin-inhibitor Reduction With Conversion at 2 Months to Everolimus/Reduced Tacrolimus in Renal Transplant Recipients Following Campath® Induction (NCT01935128) | University of Toledo Health Science Campus | 2013-07-03 |
| B Cell Lymphocyte in Humoral Rejection and Alloimmunisation (NCT03016455) | University Hospital, Brest | 2013-06-13 |
| Pharmaco-economical Study in Kidney Transplantation (NCT01989832) | University Hospital, Limoges | 2013-02-01 |
| Long-term Cardiovascular Risk Following Successful Renal Transplantation (NCT01728012) | Helse Stavanger HF | 2012-11-01 |
| Effects of Zortress® + Tacrolimus vs. Standard Immunosuppression on Progression of Coronary Artery Calcifications and Bone Disease in de Novo Renal Transplant Recipients (NCT01612299) | University of Kentucky | 2012-05-01 |
| Absence of Steroid in Renal Transplantation and Digital Fibrosis Observation (NCT01541176) | Nantes University Hospital | 2012-04-01 |
| Comparison of Medication Adherence Between Once and Twice Daily Tacrolimus in Stable Renal Transplant Recipients (NCT01334333) | University of British Columbia | 2011-11-11 |
| Identification of Markers (Klotho-FGF23 Axis) as Determinant in the Evolution of Arterial Stiffness During the First Year of Renal Transplant (NCT02951442) | Hopital Foch | 2011-01-01 |
| Advagraf/Prograf Conversion Trial (NCT01410162) | Norman Muirhead | 2010-12-01 |
| Home-Care Needs in Liver or Renal Transplantation Recipients and Their Spouses (NCT01380002) | National Taiwan University Hospital | 2010-12-01 |
| Pharmacokinetics of Generic to Brand Tacrolimus in Stable Renal Transplant Patients (NCT01256294) | Novartis | 2010-10-01 |
| 24 Months Follow-up, Two Arm Study to Compare the Cardiovascular Profile in a Regimen With Everolimus + Mycophenolic Acid (MPA) Versus (vs.) a Regimen of CNI+MPA in Maintenance Renal Transplant Recipients (NCT01169701) | Novartis Pharmaceuticals | 2010-08-01 |
| Study of Cyclosporine Withdrawal Regimen in Thai Renal Transplant Recipients (NCT01758107) | Chulalongkorn University | 2010-08-01 |
| Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection (NCT01154387) | Tolera Therapeutics, Inc | 2010-07-01 |
| Renal Allograft : Evaluation of Parenchymal Fibrosis by Elastography (NCT01234363) | Hospices Civils de Lyon | 2010-05-01 |
| Using Cinacalcet to Treat the Hypophosphatemia of Early Kidney Transplant (NCT01011114) | Montefiore Medical Center | 2009-11-01 |
| TIPE2 Associated With Kidney Transplant (NCT01059292) | Xi'an Jiaotong University | 2009-10-01 |
| Paricalcitol in Reducing Parathyroid Hormone Levels and Ameliorating Markers of Bone Remodelling in Renal Transplant Recipients With Secondary Hyperparathyroidism (NCT01220050) | Mario Negri Institute for Pharmacological Research | 2009-09-01 |
| Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients (NCT00895583) | Pfizer | 2009-06-01 |
| mTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal Transplantation (NCT01028092) | University Hospital, Brest | 2009-03-01 |
| Peginterferon Alfa-2a Plus Ribavirin Combination Treatment in Chronic Hepatitis C Post-Renal Transplant Patients (NCT00881582) | King Abdulaziz Medical City | 2009-01-01 |
| Telmisartan Versus Losartan in Kidney Transplantation (NCT01224860) | Mario Negri Institute for Pharmacological Research | 2009-01-01 |
| Study of the Influence of Plasma Exchange on the Pharmacokinetics of Rituximab (NCT00820469) | University Hospital, Toulouse | 2008-09-01 |
| CellCept® Dose Adjustment Versus Fixed Dose (Standard Care) in Renal Transplant Recipients (NCT00737659) | Rabin Medical Center | 2008-08-01 |
| Calcineurin Inhibitor Based Immunosuppression Withdrawal (NCT02117596) | Pediatric Nephrology of Alabama | 2007-11-01 |
| Study Evaluating Rapamune® Maintenance Regimen (NCT00478608) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-03-01 |
| A Study of BMS-224818 (Belatacept) in Patients Who Have Undergone a Kidney Transplant and Are Currently on Stable Cyclosporine or Tacrolimus Regimen With or Without Corticosteroids (NCT00402168) | Bristol-Myers Squibb | 2007-01-01 |
| Belatacept to Prevent Organ Rejection in Kidney Transplant Patients (NCT00346151) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-12-01 |
| Measurement of Patient Reported Outcomes in Korean Renal Transplant Patients With and Without Gastrointestinal (GI) Symptoms (NCT00529269) | Novartis Pharmaceuticals | 2006-12-01 |
| Elastographic Imaging of Renal Transplants (NCT00935727) | The University of Texas Health Science Center, Houston | 2006-06-01 |
| Intravenous Voriconazole in Patients With Renal Compromise (NCT00332410) | University of Pittsburgh | 2006-05-01 |
| Enteric-Coated Mycophenolate Sodium on Quality of Life in Patients With Gastrointestinal Symptoms Related to Mycophenolate Mofetil Therapy After Kidney Transplantation (NCT00239005) | Novartis Pharmaceuticals | 2005-09-01 |
| Study of Enteric-coated Mycophenolate Sodium Versus Mycophenolate Mofetil in Adult de Novo Renal Transplant Patients (NCT00149903) | Novartis Pharmaceuticals | 2005-01-01 |
| The Use of ACE Inhibitors in the Early Renal Post-transplant Period (NCT00270153) | Montefiore Medical Center | 2004-09-01 |
| Influence of Genes on Sirolimus Metabolism in Patients With Kidney Transplantation (NCT00352547) | National Institutes of Health Clinical Center (CC) | 2004-05-21 |
| Study of Tolerant Kidney Transplant Recipients (NCT01338779) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-05-01 |
| Measuring Kidney Function in Kidney Transplantation (NCT00212979) | Ottawa Hospital Research Institute | 2004-04-01 |
| Steroid-Free Versus Steroid-Based Immunosuppression in Pediatric Renal (Kidney) Transplantation (NCT00141037) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-03-01 |
| Pilot Study for HLA Identical Living Donor Renal Transplant Recipients (NCT00352092) | University of Cincinnati | 2002-06-01 |
| "A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52) Therapy in Primary Renal Allograft Transplantation" (NCT00365846) | University of Wisconsin, Madison | 2000-08-01 |
| Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A0107 (NCT00149916) | Novartis Pharmaceuticals | 2000-04-01 |
| Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A302 (NCT00149864) | Novartis | 2000-02-01 |
| Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A301 (NCT00149929) | Novartis | 1999-12-01 |